Mason Carrico
Stock Analyst at Stephens & Co.
(2.90)
# 907
Out of 5,182 analysts
71
Total ratings
46.03%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Overweight | $197 → $235 | $194.24 | +20.98% | 6 | Nov 13, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Overweight | $1.8 → $2 | $1.41 | +41.84% | 6 | Nov 10, 2025 | |
| NEO NeoGenomics | Maintains: Overweight | $6.5 → $11 | $8.96 | +22.77% | 2 | Sep 2, 2025 | |
| VCEL Vericel | Reiterates: Overweight | $67 | $33.46 | +100.24% | 3 | Jun 16, 2025 | |
| ILMN Illumina | Reiterates: Overweight | $105 | $141.88 | -25.99% | 8 | May 20, 2025 | |
| TXG 10x Genomics | Reiterates: Overweight | $14 | $21.60 | -35.19% | 6 | May 15, 2025 | |
| CDNA CareDx | Reiterates: Overweight | $40 | $21.85 | +83.07% | 10 | May 5, 2025 | |
| GKOS Glaukos | Maintains: Overweight | $140 → $115 | $133.52 | -13.87% | 1 | May 2, 2025 | |
| VCYT Veracyte | Reiterates: Overweight | $45 | $40.42 | +11.33% | 7 | Mar 26, 2025 | |
| GH Guardant Health | Reiterates: Overweight | $55 | $95.70 | -42.53% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $6 | $4.61 | +30.15% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $17 | $26.69 | -36.31% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 | $71.77 | -27.55% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $20 | $4.29 | +366.20% | 4 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $41 | $19.83 | +106.76% | 7 | Jan 2, 2025 |
Natera
Nov 13, 2025
Maintains: Overweight
Price Target: $197 → $235
Current: $194.24
Upside: +20.98%
Pacific Biosciences of California
Nov 10, 2025
Maintains: Overweight
Price Target: $1.8 → $2
Current: $1.41
Upside: +41.84%
NeoGenomics
Sep 2, 2025
Maintains: Overweight
Price Target: $6.5 → $11
Current: $8.96
Upside: +22.77%
Vericel
Jun 16, 2025
Reiterates: Overweight
Price Target: $67
Current: $33.46
Upside: +100.24%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $141.88
Upside: -25.99%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $21.60
Upside: -35.19%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $21.85
Upside: +83.07%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140 → $115
Current: $133.52
Upside: -13.87%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $40.42
Upside: +11.33%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $95.70
Upside: -42.53%
Mar 19, 2025
Reiterates: Overweight
Price Target: $6
Current: $4.61
Upside: +30.15%
Mar 18, 2025
Reiterates: Equal-Weight
Price Target: $17
Current: $26.69
Upside: -36.31%
Mar 6, 2025
Reiterates: Overweight
Price Target: $52
Current: $71.77
Upside: -27.55%
Jan 16, 2025
Reiterates: Equal-Weight
Price Target: $20
Current: $4.29
Upside: +366.20%
Jan 2, 2025
Reiterates: Overweight
Price Target: $41
Current: $19.83
Upside: +106.76%